J P Morgan Chase & Co set a €95.40 ($112.24) price objective on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a report published on Thursday morning. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts also recently issued reports on FME. UBS AG set a €68.00 ($80.00) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a sell rating in a research note on Friday, July 14th. Oddo Securities set a €95.00 ($111.76) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Thursday, July 20th. Goldman Sachs Group, Inc. (The) set a €98.00 ($115.29) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Monday, July 24th. Deutsche Bank AG set a €85.00 ($100.00) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a neutral rating in a research note on Monday, July 24th. Finally, Berenberg Bank set a €92.10 ($108.35) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Wednesday, July 26th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of €89.12 ($104.84).

Shares of Fresenius Medical Care AG & Co. (ETR:FME) opened at €83.20 ($97.88) on Thursday.

TRADEMARK VIOLATION NOTICE: “J P Morgan Chase & Co Analysts Give Fresenius Medical Care AG & Co. (Pref) (FME) a €95.40 Price Target” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/j-p-morgan-chase-95-40-price-target/1679544.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with Analyst Ratings Network's FREE daily email newsletter.